|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 283, Issue 49, 33975-33987, December 5, 2008
Smooth Muscle Cell Arachidonic Acid Release, Migration, and Proliferation Are Markedly Attenuated in Mice Null for Calcium-independent Phospholipase A2β*![]() ![]() ![]() ![]() ![]() ![]() ¶![]() ||**1
From the
Divisions of Pharmacologic evidence suggests that the lipid products generated by one or more calcium-independent phospholipases A2 (iPLA2s) participate in the regulation of vascular tone through smooth muscle cell (SMC) Ca2+ signaling and the release of arachidonic acid. However, the recent identification of new members of the iPLA2 family, each inhibitable by (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one, has rendered definitive identification of the specific enzyme(s) mediating these processes difficult. Accordingly, we used iPLA2β–/– mice to demonstrate that iPLA2β is responsible for the majority of thapsigargin and ionophore (A23187 [GenBank] )-induced arachidonic acid release from SMCs. Both thapsigargin and A23187 [GenBank] stimulated robust [3H]arachidonate (AA) release from wild-type aortic SMCs that was dramatically attenuated in iPLA2β–/– mice (>80% reduction at 5 min; p < 0.01). Moreover, iPLA2β–/– mice displayed defects in SMC Ca2+ homeostasis and decreased SMC migration and proliferation in a model of vascular injury. Ca2+-store depletion resulted in the rapid entry of external Ca2+ into wild-type aortic SMCs that was significantly slower in iPLA2β-null cells (p < 0.01). Furthermore, SMCs from iPLA2β-null mesenteric arterial explants demonstrated decreased proliferation and migration. The defects in migration and proliferation in iPLA2β-null SMCs were restored by 2 µM AA. Remarkably, the cyclooxygenase-2-specific inhibitor, NS-398, prevented AA-induced rescue of SMC migration and proliferation in iPLA2β–/– mice. Moreover, PGE2 alone rescued proliferation and migration in iPLA2β–/– mice. We conclude that iPLA2β is an important mediator of AA release and prostaglandin E2 production in SMCs, modulating vascular tone, cellular signaling, proliferation, and migration.
Received for publication, July 29, 2008 , and in revised form, October 7, 2008. * This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278-10 and 2RO1HL41250-13. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 To whom correspondence should be addressed: Division of Bioorganic Chemistry and Molecular Pharmacology, Washington University School of Medicine, 660 South Euclid Ave., Campus Box 8020, St. Louis, MO 63110. Tel.: 314-362-2690; Fax: 314-362-1402; E-mail: rgross{at}wustl.edu.
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||